CanBas Co Ltd 4575.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
505.00quote price arrow up+8.00 (+1.61%)
Volume
40,300
52 week range
423.00 - 898.00

...

Loading . . .

KEY STATS

  • Open500.00
  • Day High506.00
  • Day Low498.00
  • Prev Close497.00
  • 52 Week High898.00
  • 52 Week High Date06/18/20
  • 52 Week Low423.00
  • 52 Week Low Date01/05/21
  • Market Cap35.73M
  • Shares Out7.31M
  • 10 Day Average Volume272,100
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-29.86

RATIOS/PROFITABILITY

  • EPS (TTM)-70.30
  • P/E (TTM)-7.18
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest CanBas Co Ltd News

There is no recent news for this security.

Latest 4575.T-JP News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
CanBas Co., Ltd. is engaged in research and development of anticancer drugs which have little influence to the normal cells. In the general medicinal products development process, the Company is engaged in the exploration of compounds in accordance with the medicinal products subjects; the improvement of the compounds; the verification of the compounds on the animals; the application of investigational new drug (IND), as well as the initial stage of clinical investigation...
Takumi Kawabe M.D., Ph.D
President
Makoto Katozumi
Chief Financial Officer
Address
2-2-1, Ote-machi
Numazu-shi, SZK
410-0801
Japan